Takeda Pharmaceutical Company Limited
Takeda Responds to the FDA Advisory Committee Recommendation
London (ots/PRNewswire) - Following a joint meeting today of the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development (TGRD) underscores its position that ACTOS(R) (pioglitazone HCl) offers a proven safety profile regarding the risk of cardiovascular disease. "The breadth ...